Delivery Order SPE2DB22D2007-SPE2DB24FJ2ZZ
- Not listed
- This federal contract award, with ID SPE2DB22D1106|SPE2DB24FFFB7, is a Delivery Order issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the supply of 4565320231 - ZOLMITRIPTAN 5 MG NASAL SPRAY 6S, a pharmaceutical product. The contract has a firm fixed price of $5,412.41 and an ultimate completion date of August 2, 2024. The contract is not set aside for any specific business category....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,217.14, is for a delivery order of ZOLMITRIPTAN 5 MG NASAL SPRAY 6S. The contract is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, identified as SPE2DX15D3007|SPE2DX24F9N8D, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,109.33 firm fixed-price delivery order is for the supply of ZOLMITRIPTAN 5 MG NASAL SPRAY 6S, a pharmaceutical product. This contract has an ultimate completion date of August 6, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZOLMITRIPTAN 5 MG NASAL SPRAY 6S, a pharmaceutical product, with a ceiling value of $5,687.33 and a completion date of June 12, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,818.40 firm fixed-price delivery order is for the supply of ZOLMITRIPTAN 5 MG NASAL SPRAY 6S, a prescription medication. The contract has an ultimate completion date of August 21, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $2,446.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ZOLMITRIPTAN 5 MG NASAL SPRAY 6S, a medical commodity to support federal healthcare programs. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The $1,061.31 firm fixed price delivery order is for the supply of 4565505447 ZOLMITRIPTAN 5 MG NASAL SPRAY 6S, a pharmaceutical product. The contract has an ultimate completion date of August 20, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,603.79 firm fixed-price delivery order is for the supply of 4567268081 ZOLMITRIPTAN 5 MG NASAL SPRAY 6S, with a period of performance through February 14, 2025. The contract is not designated as a set-aside award. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $21,186.32 firm fixed-price delivery order is for the provision of 4564376412 - Zolmitriptan 5 mg Nasal Spray 6s, with a contract period of performance through April 24, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to deliver a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,322.77 firm-fixed-price delivery order is for the supply of Zolmitriptan 5 mg nasal spray, with a period of performance through October 28, 2024. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ2ZZDelivery Order
This federal contract award, identified as SPE2DB22D2007|SPE2DB24FJ2ZZ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office division. The contract, valued at $8,965.52, is a delivery order for the supply of ZOLMITRIPTAN 5 MG NASAL SPRAY 6S, a pharmaceutical product. The contract has a firm fixed price and is set to be completed by June 3, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to various federal agencies, with a particular focus on serving the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The company holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 5/31/24 |